Stocks AstraZeneca PLC

More

  • The Board of Governors of the Federal Reserve seal is displayed on the floor outside the board room in Washington, D.C.

    European markets posted strong gains during Thursday's session, closing higher, after the Fed announced its first rate rise in almost a decade.

  • *Casino slumps after Muddy Waters note. LONDON/ MILAN, Dec 17- European shares surged on Thursday as investors took the U.S. The pan-European FTSEurofirst 300 index was up 1.6 percent by 1530 GMT after climbing to a one-week high, while Germany's DAX, France's CAC and Britain's FTSE 100 rose between 3 to 1 percent.

  • Traders work on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • A post-Fed stock rally this morning, following the central banks first interest rate increase in more than nine years.

  • Cancer research in the U.K.

    Cancer is mostly a result of external, environmental risk factors rather than down to "bad luck," according to a new study.

  • *AstraZeneca says acalabrutinib sales could top $5 bln/ yr. LONDON, Dec 17- AstraZeneca said on Thursday it had agreed to buy 55 percent stake of privately held biotech firm Acerta Pharma for $4.0 billion to give it access to a new kind of drug for fighting blood cancers. AstraZeneca will pay $2.5 billion upfront, with a further $1.5 billion paid either on receipt of...

  • LONDON, Dec 17- AstraZeneca said on Thursday it had agreed to buy a 55 percent stake in privately held biotech firm Acerta Pharma for $4.0 billion to give it access to a new kind of drug for fighting blood cancers.

  • BRIEF-ASTRAZENECA TAKES $2.5 BLN INVESTMENT IN ACERTA@. *enhances long term growth through oncology investment in Acerta Pharma. *Under the terms of the agreement, AstraZeneca will acquire 55 percent of the entire issued share capital of Acerta for an upfront payment of $2.5 billion.

  • LONDON, Dec 16- AstraZeneca aims to build up its already strong position in China by making and developing more medicines locally, and will invest more than $800 million in the country over the next 10 years, it said on Wednesday. "We don't want to have drugs that are approved in the U.S. and elsewhere and it then takes another five or six years to bring them to patients...

  • Traders work on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • Stock futures turned negative this morning after being up strongly, as crude falls sharply to under $34 a barrel.

  • *AstraZeneca confirms talks with biotech firm Acerta. LONDON, Dec 14- AstraZeneca said on Monday it was in talks that might lead to the acquisition of privately held biotech firm Acerta Pharma, a potential $5 billion- plus deal designed to build up its cancer drug portfolio. "AstraZeneca confirms that it is exploring potential strategic options with Acerta...

  • LONDON, Dec 14- AstraZeneca said on Monday it was in talks with privately held cancer drug developer Acerta Pharma, after the Wall Street Journal reported on Friday it was looking to acquire the business for more than $5 billion. "AstraZeneca confirms that it is exploring potential strategic options with Acerta Pharma BV. There can be no certainty that any...

  • Dec 10- Data integrator SnapLogic said on Thursday it raised $37.5 million in funding from Microsoft Corp and Silver Lake Waterman, which it plans to use to accelerate growth and for expansion. The San Mateo, California- based company's previous investors include Ignition Partners, Triangle Peak Partners and Andreessen Horowitz. SnapLogic, whose customers...

  • Dec 10- Data integrator SnapLogic said on Thursday it raised $37.5 million in funding from Microsoft Corp and venture capital firm Silver Lake Waterman. The San Mateo, California- based company's previous investors include Ignition Partners, Triangle Peak Partners and Andreessen Horowitz. SnapLogic, whose customers include Adobe Systems Inc and...

  • Dec 2- Cloud storage provider Box Inc raised its full-year revenue forecast for the third time as more users sign up for its services. Box, whose customers include AstraZeneca Plc, General Electric Co and Procter& Gamble Co, said it expects revenue of $299 million- $300 million for the year ending January, up from its previous forecast of $295- $297 million.

  • Euro

    European equities closed the session mixed Wednesday as investors digested inflation numbers and contemplated the possibility of further stimulus.

  • Prescription drugs

    An FDA rule created to spur drug companies to develop treatments for rare diseases is being used far beyond its original scope, critics say.

  • *Local drugs intensify competition as China squeezes prices. SHANGHAI, Nov 29- China, already a global powerhouse in high-tech areas from solar panels to bullet trains, is turning its industrial might to the challenge of making more of its own drugs for a vast and aging population. That has made China a sweet spot for Denmark's Novo Nordisk; the world's biggest...

  • Pfizer's proposed acquisition of Allergan will be one of the biggest tax inversions yet.